| Literature DB >> 35140982 |
Xiaoling Pan1,2, Delin Cheng3, Changshun Ruan3, Yonglong Hong2, Cheng Lin2.
Abstract
Bone regeneration-related graphene-based materials (bGBMs) are increasingly attracting attention in tissue engineering due to their special physical and chemical properties. The purpose of this review is to quantitatively analyze mass academic literature in the field of bGBMs through scientometrics software CiteSpace, to demonstrate the rules and trends of bGBMs, thus to analyze and summarize the mechanisms behind the rules, and to provide clues for future research. First, the research status, hotspots, and frontiers of bGBMs are analyzed in an intuitively and vividly visualized way. Next, the extracted important subjects such as fabrication techniques, cytotoxicity, biodegradability, and osteoinductivity of bGBMs are presented, and the different mechanisms, in turn, are also discussed. Finally, photothermal therapy, which is considered an emerging area of application of bGBMs, is also presented. Based on this approach, this work finds that different studies report differing opinions on the biological properties of bGBMS due to the lack of consistency of GBMs preparation. Therefore, it is necessary to establish more standards in fabrication, characterization, and testing for bGBMs to further promote scientific progress and clinical translation.Entities:
Keywords: CiteSpace; bone tissue engineering; graphene; nanomedicine; scientometrics
Year: 2021 PMID: 35140982 PMCID: PMC8812920 DOI: 10.1002/gch2.202100107
Source DB: PubMed Journal: Glob Chall ISSN: 2056-6646
Figure 1A) Number of yearly publications on bGBMs (2011–2020). B) The network of subject distribution. C) The network of contribution and cooperation of countries. D) The network of contribution and cooperation of institutions.
Figure 2A) The network of co‐occurrence keywords. B) The network of cocitation references.
Figure 3Classification of the 235 keywords according to the themes of GFMs members, composites, fabrication techniques, application forms, applications for BTE, and controversy. The frequency of keyword occurrences is numerically marked in parentheses.
The 13 clusters of co‐occurrence keywords
| Cluster ID | Size | Silhouette | Mean [year] | Label (LLR) |
|---|---|---|---|---|
| 0 | 25 | 0.869 | 2016 | Spontaneous osteogenic differentiation |
| 1 | 24 | 0.951 | 2014 | Porous biopolymer hybrid |
| 2 | 21 | 0.979 | 2014 | Biological responses |
| 3 | 19 | 0.921 | 2018 | One‐step preparation |
| 4 | 19 | 0.852 | 2016 | Mechanical properties |
| 5 | 18 | 0.865 | 2016 | Bone cancer treatment |
| 6 | 17 | 0.894 | 2017 | Carbon‐based nanomaterial |
| 7 | 16 | 0.871 | 2016 | Functional graphene nanomaterial |
| 8 | 16 | 0.927 | 2017 | Additive manufacturing |
| 9 | 15 | 0.898 | 2014 | Few‐layer graphene |
| 10 | 15 | 0.976 | 2016 | Biomedical applications |
| 11 | 11 | 0.98 | 2014 | Controlled drug delivery |
| 12 | 9 | 0.842 | 2016 | Antibacterial properties |
The 15 clusters of cocitation references
| Cluster ID | Size | Silhouette | Mean [year] | Label (LLR) |
|---|---|---|---|---|
| 0 | 45 | 0.845 | 2014 | Nanocomposite scaffold |
| 1 | 42 | 0.957 | 2011 | Reduced graphene oxide |
| 2 | 40 | 0.922 | 2013 | Drug‐eluting capacity |
| 3 | 38 | 0.855 | 2016 | Enhanced photothermal therapy |
| 4 | 35 | 0.928 | 2011 | Functionalized graphene oxide |
| 5 | 35 | 0.895 | 2017 | 3D‐printed graphene |
| 6 | 34 | 0.772 | 2011 | Nanocarbon‐based material |
| 7 | 33 | 0.923 | 2014 | Enhanced cell proliferation |
| 8 | 32 | 0.924 | 2013 | Osteoinductive factor |
| 9 | 32 | 0.932 | 2009 | Oxide‐mediated cellular response |
| 10 | 29 | 0.91 | 2015 | Enhanced osteoinductivity |
| 11 | 27 | 0.912 | 2008 | Few‐layer graphene |
| 12 | 24 | 0.943 | 2010 | Biodegradable polymeric nanocomposites |
| 13 | 23 | 0.857 | 2013 | Alveolar bone regeneration |
| 14 | 14 | 0.99 | 2010 | Fast osteogenic differentiation |
Figure 4The schematic diagram of the reported cytotoxic mechanism of GFMs. I) Intracellular dysfunction. II) Protein corona. III) Extracting phospholipid. IV) Physical damage to the membrane. V) Membrane coverage.
Figure 5The schematic diagram of the reported biodegradation mechanism of GFMs by macrophage.
Figure 6A schematic view of the complex network of the GFMs mediated signaling pathways in regulating bone regeneration.
Figure 7A) Schematic illustration of synergistic photocatalytic antibacterial and osseointegration via coupling CuS@BSA NPs and rGO. Reproduced with permission.[ ] Copyright 2021, Elsevier Ltd. B) Schematic illustration of the fabrication of nHA/GO particles, nHA/GO/CS scaffolds, and their bioapplication. Reproduced with permission.[ ] Copyright 2020, Elsevier Ltd. C) Schematic illustration of the fabrication of the multifunctional sPEEK a) and its triple‐model therapeutic effects b). Reproduced with permission.[ ] Copyright 2020, ACS Publications.
PTT applications of bGBMs
| bGBMs | Laser parameters | Targeted temperature | Therapeutic effect under NIR | Bone regeneration | Ref. | |
|---|---|---|---|---|---|---|
| Under NIR | Without NIR | |||||
| CuS/rGO | 808 nm, 2 W cm−2, 600 s | 52.3 °C | Antimicrobial | – | Promoted vascularized osseointegration |
[
|
| GR/HA/Gelatin | 808 nm, 1 W cm−2, 180 s | 43 °C. | – | Mild photothermal environment accelerated bone regeneration. | – |
[
|
| CS/rGO loading Teriparatide | 808 nm, 0.5 W cm−2, 10 min | 48 °C | Trigger delivery of anticancer drug | – | Improved osteoporotic bone defect repair |
[
|
| CePO4/CS/GO | In vitro: 808 nm, 4.6 W cm−2, 5 min; In vivo: 0.55 W cm−2, 10 min | In vitro: 51.4 °C; In vivo: 52 °C | Anticancer | – | Regulated macrophage polarization to improve the osteoinductive ability |
[
|
| GO/pDA | 808 nm, 0.5 W/cm−2, 10 min | 47.6 °C | Antimicrobial | – | Boosted in vivo osseointegration and bone remodeling |
[
|
| nHA/GO/CS | 808 nm, 2 W cm−2, 5 min; 1 W cm−2, 60 s | 2 W cm−2, 48 °C, 1 W cm−2, 42 °C | Anticancer | Promoting osteogenesis, hemostasis, and soft tissue repair under irradiation | – |
[
|
| PEEK/GO | 808 nm, 0.43 W cm−2, 150 s | 45 °C | Anticancer and Antimicrobial | – | Promoted new bone tissue formation. |
[
|
| sPEEK/GO/APN | 808 nm, 0.5 W cm−2, 10 min | 50.4 °C | Antimicrobial | – | Boosted bone regeneration and osseointegration |
[
|
| CS/GO | 808 nm, 0.66 W cm−2, 10 min | 55 °C | Anticancer | – | Promoted the proliferation and differentiation of MC3T3‐E1 |
[
|
| CS/nHA/CD | 808 nm, 1 W cm−2, 10 min | 51.4 °C | Anticancer and Antimicrobial | – | Enhanced osteoinductivity |
[
|
| nHA‐rGO | 808 nm, 1.0 W cm−2, 10 min | 77 °C | Anticancer | – | Promoted large‐format bone defect repair |
[
|
| GO‐TCP | 808 nm, 0.36 W cm−2, 10 min | 52 °C | Anticancer | – | Promoted new bone formation |
[
|